• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与电子健康记录系统相连的慢性淋巴细胞白血病治疗感染模型的部署与验证。

Deployment and validation of the CLL treatment infection model adjoined to an EHR system.

作者信息

Agius Rudi, Riis-Jensen Anders C, Wimmer Bettina, da Cunha-Bang Caspar, Murray Daniel Dawson, Poulsen Christian Bjorn, Bertelsen Marianne B, Schwartz Berit, Lundgren Jens Dilling, Langberg Henning, Niemann Carsten Utoft

机构信息

Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

SP Sundhedsdata, The Data Unit, Capital Region of Denmark, Copenhagen, Denmark.

出版信息

NPJ Digit Med. 2024 Jun 5;7(1):147. doi: 10.1038/s41746-024-01132-6.

DOI:10.1038/s41746-024-01132-6
PMID:38839920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11153589/
Abstract

Research algorithms are seldom externally validated or integrated into clinical practice, leaving unknown challenges in deployment. In such efforts, one needs to address challenges related to data harmonization, the performance of an algorithm in unforeseen missingness, automation and monitoring of predictions, and legal frameworks. We here describe the deployment of a high-dimensional data-driven decision support model into an EHR and derive practical guidelines informed by this deployment that includes the necessary processes, stakeholders and design requirements for a successful deployment. For this, we describe our deployment of the chronic lymphocytic leukemia (CLL) treatment infection model (CLL-TIM) as a stand-alone platform adjoined to an EPIC-based Danish Electronic Health Record (EHR), with the presentation of personalized predictions in a clinical context. CLL-TIM is an 84-variable data-driven prognostic model utilizing 7-year medical patient records and predicts the 2-year risk composite outcome of infection and/or treatment post-CLL diagnosis. As an independent validation cohort for this deployment, we used a retrospective population-based cohort of patients diagnosed with CLL from 2018 onwards (n = 1480). Unexpectedly high levels of missingness for key CLL-TIM variables were exhibited upon deployment. High dimensionality, with the handling of missingness, and predictive confidence were critical design elements that enabled trustworthy predictions and thus serves as a priority for prognostic models seeking deployment in new EHRs. Our setup for deployment, including automation and monitoring into EHR that meets Medical Device Regulations, may be used as step-by-step guidelines for others aiming at designing and deploying research algorithms into clinical practice.

摘要

研究算法很少经过外部验证或整合到临床实践中,这在部署过程中留下了未知的挑战。在这类工作中,需要应对与数据协调、算法在意外数据缺失情况下的性能、预测的自动化和监测以及法律框架相关的挑战。我们在此描述将一个高维数据驱动的决策支持模型部署到电子健康记录(EHR)中的情况,并根据此次部署得出实用指南,其中包括成功部署所需的流程、利益相关者和设计要求。为此,我们将慢性淋巴细胞白血病(CLL)治疗感染模型(CLL-TIM)作为一个独立平台进行部署,该平台与基于EPIC的丹麦电子健康记录(EHR)相连,并在临床背景下呈现个性化预测。CLL-TIM是一个包含84个变量的数据驱动预后模型,利用7年的患者医疗记录,预测CLL诊断后2年感染和/或治疗的综合风险结果。作为此次部署的独立验证队列,我们使用了一个基于人群的回顾性队列,该队列中的患者自2018年起被诊断为CLL(n = 1480)。在部署时,关键CLL-TIM变量出现了意外的高缺失水平。高维度、缺失值处理以及预测置信度是关键的设计要素,这些要素能够实现可靠的预测,因此对于寻求在新的电子健康记录中部署的预后模型而言是优先考虑的因素。我们的部署设置,包括符合医疗器械法规的电子健康记录自动化和监测,可为其他旨在将研究算法设计和部署到临床实践中的人员提供分步指南。

相似文献

1
Deployment and validation of the CLL treatment infection model adjoined to an EHR system.与电子健康记录系统相连的慢性淋巴细胞白血病治疗感染模型的部署与验证。
NPJ Digit Med. 2024 Jun 5;7(1):147. doi: 10.1038/s41746-024-01132-6.
2
Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.仅使用廉价检测指标进行慢性淋巴细胞白血病治疗预测的可解释机器学习
Comput Biol Med. 2022 Jun;145:105490. doi: 10.1016/j.compbiomed.2022.105490. Epub 2022 Apr 6.
3
Machine learning can identify newly diagnosed patients with CLL at high risk of infection.机器学习可以识别新诊断出的 CLL 患者中感染风险较高的患者。
Nat Commun. 2020 Jan 17;11(1):363. doi: 10.1038/s41467-019-14225-8.
4
Development and Deployment of the OpenMRS-Ebola Electronic Health Record System for an Ebola Treatment Center in Sierra Leone.为塞拉利昂一家埃博拉治疗中心开发和部署OpenMRS-埃博拉电子健康记录系统
J Med Internet Res. 2017 Aug 21;19(8):e294. doi: 10.2196/jmir.7881.
5
Integrating Option Grid Patient Decision Aids in the Epic Electronic Health Record: Case Study at 5 Health Systems.在 Epic 电子健康记录中整合选项网格患者决策辅助工具:5 个卫生系统的案例研究。
J Med Internet Res. 2021 May 3;23(5):e22766. doi: 10.2196/22766.
6
Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies.为真实世界证据生成可分析数据:利用先进信息学技术驾驭电子健康记录的教程。
J Med Internet Res. 2023 May 25;25:e45662. doi: 10.2196/45662.
7
The Danish National Chronic Lymphocytic Leukemia Registry.丹麦国家慢性淋巴细胞白血病登记处。
Clin Epidemiol. 2016 Oct 25;8:561-565. doi: 10.2147/CLEP.S99486. eCollection 2016.
8
Imputation and missing indicators for handling missing data in the development and deployment of clinical prediction models: A simulation study.处理临床预测模型开发和部署中缺失数据的插补和缺失指标:一项模拟研究。
Stat Methods Med Res. 2023 Aug;32(8):1461-1477. doi: 10.1177/09622802231165001. Epub 2023 Apr 27.
9
Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Predict Postoperative Complications and Report on a Mobile Platform.基于电子健康记录数据的机器学习算法预测术后并发症的性能及移动平台报告。
JAMA Netw Open. 2022 May 2;5(5):e2211973. doi: 10.1001/jamanetworkopen.2022.11973.
10
Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy.研究慢性淋巴细胞白血病中的脂肪酸代谢,以指导临床结局和治疗。
Ann Hematol. 2024 Apr;103(4):1241-1254. doi: 10.1007/s00277-023-05590-y. Epub 2023 Dec 27.

引用本文的文献

1
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.单克隆B淋巴细胞增多症(MBL)的生物学前沿、进展及临床管理:血液癌症拦截研讨会委员会共识报告
Blood Cancer J. 2025 Aug 29;15(1):148. doi: 10.1038/s41408-025-01341-6.
2
Elucidating novel immune profiles for predicting infection in high-risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia.阐明用于预测高危人群感染的新型免疫特征:复发难治性慢性淋巴细胞白血病患者的一项试点研究。
Clin Transl Immunology. 2025 Aug 3;14(8):e70049. doi: 10.1002/cti2.70049. eCollection 2025.
3

本文引用的文献

1
Using sequences of life-events to predict human lives.利用生命事件序列预测人类生命。
Nat Comput Sci. 2024 Jan;4(1):43-56. doi: 10.1038/s43588-023-00573-5. Epub 2023 Dec 18.
2
Validation of risk prediction models applied to longitudinal electronic health record data for the prediction of major cardiovascular events in the presence of data shifts.应用于纵向电子健康记录数据的风险预测模型在存在数据偏移情况下对主要心血管事件预测的验证
Eur Heart J Digit Health. 2022 Oct 21;3(4):535-547. doi: 10.1093/ehjdh/ztac061. eCollection 2022 Dec.
3
Artificial intelligence-based methods for fusion of electronic health records and imaging data.
A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma.
一种用于新诊断多发性骨髓瘤患者的真实世界国际分期系统(RW-ISS)。
Blood Cancer J. 2025 Apr 7;15(1):59. doi: 10.1038/s41408-025-01268-y.
4
The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.丹麦淋巴瘤癌症研究(DALY-CARE)数据资源:发展数据驱动血液学的基础。
Clin Epidemiol. 2025 Feb 20;17:131-145. doi: 10.2147/CLEP.S479672. eCollection 2025.
基于人工智能的电子健康记录与医学影像数据融合方法。
Sci Rep. 2022 Oct 26;12(1):17981. doi: 10.1038/s41598-022-22514-4.
4
Clinical artificial intelligence quality improvement: towards continual monitoring and updating of AI algorithms in healthcare.临床人工智能质量改进:迈向医疗保健中人工智能算法的持续监测与更新
NPJ Digit Med. 2022 May 31;5(1):66. doi: 10.1038/s41746-022-00611-y.
5
Developing, implementing and governing artificial intelligence in medicine: a step-by-step approach to prevent an artificial intelligence winter.在医学中开发、实施和治理人工智能:预防人工智能寒冬的逐步方法。
BMJ Health Care Inform. 2022 Feb;29(1). doi: 10.1136/bmjhci-2021-100495.
6
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.CLL12 试验:伊布替尼对比安慰剂用于初治、早期慢性淋巴细胞白血病。
Blood. 2022 Jan 13;139(2):177-187. doi: 10.1182/blood.2021010845.
7
Artificial intelligence models in chronic lymphocytic leukemia - recommendations toward state-of-the-art.慢性淋巴细胞白血病中的人工智能模型——迈向最新技术水平的建议
Leuk Lymphoma. 2022 Feb;63(2):265-278. doi: 10.1080/10428194.2021.1973672. Epub 2021 Oct 6.
8
MetaPred: Meta-Learning for Clinical Risk Prediction with Limited Patient Electronic Health Records.MetaPred:利用有限患者电子健康记录进行临床风险预测的元学习
KDD. 2019 Aug;2019:2487-2495. doi: 10.1145/3292500.3330779.
9
How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals.医学人工智能设备的评估方式:基于对美国食品药品监督管理局批准情况分析的局限性与建议
Nat Med. 2021 Apr;27(4):582-584. doi: 10.1038/s41591-021-01312-x.
10
External validation of prognostic models: what, why, how, when and where?预后模型的外部验证:是什么、为什么、如何、何时以及何地?
Clin Kidney J. 2020 Nov 24;14(1):49-58. doi: 10.1093/ckj/sfaa188. eCollection 2021 Jan.